BASi Reports Fourth Quarter And Full Year 2014 Results

Bioanalytical Systems, Inc. (NASDAQ:BASI) today announced financial results for the fourth quarter and the full fiscal year ended September 30, 2014.

“BASi’s operating financial performance for fiscal 2014 showed significant improvement over last year, as revenue increased by 11.4%. Net income before the change in fair value of the warrant liability and before goodwill impairment increased 29% to $222,000 for fiscal 2014, or $0.03 per diluted share, compared to $172,000, or $0.02 per diluted share, for fiscal 2013. EBITDA for fiscal 2014 was a solid 9.8% of revenue, not as high as the 12.6% of revenue reported for 2013, but reflective of targeted investments in selling, research & development and growth initiatives which will improve the Company’s ability to deliver profitable growth.

Help employers find you! Check out all the jobs and post your resume.

Back to news